| Mohinder Vindhyal, MD | |
|
8929 Parallel Pkwy, Kansas City, KS 66112-1689 | |
| (913) 596-4168 | |
| (913) 596-4650 |
| Full Name | Mohinder Vindhyal |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 8929 Parallel Pkwy, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205198967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0000X | Internal Medicine - Adolescent Medicine | 9407835 (Kansas) | Secondary |
| 208M00000X | Hospitalist | 04-39158 (Kansas) | Primary |
| Entity Name | University Of Kansas School Of Medicine Wichita Medical Practice Assoc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639143712 PECOS PAC ID: 3577464841 Enrollment ID: O20040119000674 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
| Entity Name | Prime Healthcare Physician Services - Providence Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356683213 PECOS PAC ID: 1052553906 Enrollment ID: O20130806000598 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20151112002441 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas-tcg Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902384464 PECOS PAC ID: 3678825312 Enrollment ID: O20200127001753 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20220121000611 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohinder Vindhyal, MD 1010 N. Kansas, Department Of Internal Medicine, Wichita, KS 67214 Ph: (316) 293-2604 | Mohinder Vindhyal, MD 8929 Parallel Pkwy, Kansas City, KS 66112-1689 Ph: (913) 596-4168 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.
Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
› Verified 3 days ago
Aiman Zafar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6000 | |
Michael Aaron Albrecht, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Olathe Blvd, Kansas City, KS 66160 Phone: 913-945-8184 Fax: 913-588-6055 | |
Muhammad Atif Khan, MD Hospitalist Medicare: Medicare Enrolled Practice Location: University Of Kansas Health System. 4000 Cambridge St, 6040 Delp Ms 1020, Kansas City, KS 66160 Phone: 913-588-5165 | |
Mohammad Taha, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Ku Medical Center Div Og General &, 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160 Phone: 913-588-6005 Fax: 913-588-3877 | |
Bidhan Kunwar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Michael Burton, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5080 Fax: 913-588-6055 | |
Margaret Nulton, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 |